Erasca Shares Are Trading Higher After the Company Announced That It Entered Into Exclusive License Agreements for Two Preclinical RAS Programs
Erasca宣布为两个临床前RAS项目签订独家许可协议后,该公司股价走高
Erasca Shares Are Trading Higher After the Company Announced That It Entered Into Exclusive License Agreements for Two Preclinical RAS Programs
Erasca宣布为两个临床前RAS项目签订独家许可协议后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧